Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy

PURPOSE: The aim of our study is to evaluate the undergrading and understaging rates in patients with clinically localized insignificant prostate cancer who underwent radical prostatectomy. MATERIALS AND METHODS: Between July 2005 and July 2008, 406 patients underwent radical prostatectomy for clinical localized prostate cancer in our hospital. Based on preoperative data, 93 of these patients fulfilled our criteria of non-significance: Gleason score < 7, stage T1c, PSA < 10 ng/mL and percentage of affected fragments less than 25%. The pathologic stage and Gleason score were compared to preoperative data to evaluate the rate of understaging and undergrading. The biochemical recurrence free survival of these operated insignificant cancers were also evaluated. RESULTS: On surgical specimen analysis 74.7% of patients had Gleason score of 6 or less and 25.3% had Gleason 7 or greater. Furthermore 8.3% of cases showed extracapsular extension. After 36 months of follow-up 3.4% had biochemical recurrence, defined by a PSA above 0.4 ng/mL. CONCLUSIONS: Despite the limited number of cases, we have found considerable rates of undergrading and understaging in patients with prostate cancer whose current definitions classified them as candidates for active surveillance. According to our results the current definition seems inadequate as up to a third of patients had higher grade or cancer outside the prostate.

Saved in:
Bibliographic Details
Main Authors: Oliveira,Irai S., Pontes-Junior,Jose, Abe,Daniel K., Crippa,Alexandre, Dall’Oglio,Marcos F., Nesralah,Adriano J., Leite,Katia R. M., Reis,Sabrina T., Srougi,Miguel
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Urologia 2010
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382010000300005
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1677-55382010000300005
record_format ojs
spelling oai:scielo:S1677-553820100003000052010-08-12Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomyOliveira,Irai S.Pontes-Junior,JoseAbe,Daniel K.Crippa,AlexandreDall’Oglio,Marcos F.Nesralah,Adriano J.Leite,Katia R. M.Reis,Sabrina T.Srougi,Miguel prostate neoplasms Gleason score prostatectomy PURPOSE: The aim of our study is to evaluate the undergrading and understaging rates in patients with clinically localized insignificant prostate cancer who underwent radical prostatectomy. MATERIALS AND METHODS: Between July 2005 and July 2008, 406 patients underwent radical prostatectomy for clinical localized prostate cancer in our hospital. Based on preoperative data, 93 of these patients fulfilled our criteria of non-significance: Gleason score < 7, stage T1c, PSA < 10 ng/mL and percentage of affected fragments less than 25%. The pathologic stage and Gleason score were compared to preoperative data to evaluate the rate of understaging and undergrading. The biochemical recurrence free survival of these operated insignificant cancers were also evaluated. RESULTS: On surgical specimen analysis 74.7% of patients had Gleason score of 6 or less and 25.3% had Gleason 7 or greater. Furthermore 8.3% of cases showed extracapsular extension. After 36 months of follow-up 3.4% had biochemical recurrence, defined by a PSA above 0.4 ng/mL. CONCLUSIONS: Despite the limited number of cases, we have found considerable rates of undergrading and understaging in patients with prostate cancer whose current definitions classified them as candidates for active surveillance. According to our results the current definition seems inadequate as up to a third of patients had higher grade or cancer outside the prostate.info:eu-repo/semantics/openAccessSociedade Brasileira de UrologiaInternational braz j urol v.36 n.3 20102010-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382010000300005en10.1590/S1677-55382010000300005
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Oliveira,Irai S.
Pontes-Junior,Jose
Abe,Daniel K.
Crippa,Alexandre
Dall’Oglio,Marcos F.
Nesralah,Adriano J.
Leite,Katia R. M.
Reis,Sabrina T.
Srougi,Miguel
spellingShingle Oliveira,Irai S.
Pontes-Junior,Jose
Abe,Daniel K.
Crippa,Alexandre
Dall’Oglio,Marcos F.
Nesralah,Adriano J.
Leite,Katia R. M.
Reis,Sabrina T.
Srougi,Miguel
Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy
author_facet Oliveira,Irai S.
Pontes-Junior,Jose
Abe,Daniel K.
Crippa,Alexandre
Dall’Oglio,Marcos F.
Nesralah,Adriano J.
Leite,Katia R. M.
Reis,Sabrina T.
Srougi,Miguel
author_sort Oliveira,Irai S.
title Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy
title_short Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy
title_full Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy
title_fullStr Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy
title_full_unstemmed Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy
title_sort undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy
description PURPOSE: The aim of our study is to evaluate the undergrading and understaging rates in patients with clinically localized insignificant prostate cancer who underwent radical prostatectomy. MATERIALS AND METHODS: Between July 2005 and July 2008, 406 patients underwent radical prostatectomy for clinical localized prostate cancer in our hospital. Based on preoperative data, 93 of these patients fulfilled our criteria of non-significance: Gleason score < 7, stage T1c, PSA < 10 ng/mL and percentage of affected fragments less than 25%. The pathologic stage and Gleason score were compared to preoperative data to evaluate the rate of understaging and undergrading. The biochemical recurrence free survival of these operated insignificant cancers were also evaluated. RESULTS: On surgical specimen analysis 74.7% of patients had Gleason score of 6 or less and 25.3% had Gleason 7 or greater. Furthermore 8.3% of cases showed extracapsular extension. After 36 months of follow-up 3.4% had biochemical recurrence, defined by a PSA above 0.4 ng/mL. CONCLUSIONS: Despite the limited number of cases, we have found considerable rates of undergrading and understaging in patients with prostate cancer whose current definitions classified them as candidates for active surveillance. According to our results the current definition seems inadequate as up to a third of patients had higher grade or cancer outside the prostate.
publisher Sociedade Brasileira de Urologia
publishDate 2010
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382010000300005
work_keys_str_mv AT oliveirairais undergradingandunderstaginginpatientswithclinicallyinsignificantprostatecancerwhounderwentradicalprostatectomy
AT pontesjuniorjose undergradingandunderstaginginpatientswithclinicallyinsignificantprostatecancerwhounderwentradicalprostatectomy
AT abedanielk undergradingandunderstaginginpatientswithclinicallyinsignificantprostatecancerwhounderwentradicalprostatectomy
AT crippaalexandre undergradingandunderstaginginpatientswithclinicallyinsignificantprostatecancerwhounderwentradicalprostatectomy
AT dallogliomarcosf undergradingandunderstaginginpatientswithclinicallyinsignificantprostatecancerwhounderwentradicalprostatectomy
AT nesralahadrianoj undergradingandunderstaginginpatientswithclinicallyinsignificantprostatecancerwhounderwentradicalprostatectomy
AT leitekatiarm undergradingandunderstaginginpatientswithclinicallyinsignificantprostatecancerwhounderwentradicalprostatectomy
AT reissabrinat undergradingandunderstaginginpatientswithclinicallyinsignificantprostatecancerwhounderwentradicalprostatectomy
AT srougimiguel undergradingandunderstaginginpatientswithclinicallyinsignificantprostatecancerwhounderwentradicalprostatectomy
_version_ 1756428069451595776